Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Long

Showing results (31-40 of 1,614) with videos related to

Pageof 162
Sort By:
Biosensors|December 27, 2024
Entropy-Driven Molecular Beacon Assisted Special RCA Assay with Enhanced Sensitivity for Room Temperature DNA BiosensingShurui Tao, Yi Long, Guozhen Liu
Biochemical Genetics|July 14, 2023
Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and Prognosis BiomarkersLi Yang, Yi Long, Shengshi Xiao
Biosensors & Bioelectronics|December 25, 2010
Sensitive and isothermal electrochemiluminescence gene-sensing of Listeria monocytogenes with hyperbranching rolling circle amplification technologyYi Long, Xiaoming Zhou, Da Xing
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[Survival and Prognosis Analysis of 57 Patients with Multiple Myeloma]Yi-Fei Chen, Yi-Long Lu
Oncotargets and Therapy|May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibFei-Yu Niu, Yi-Long Wu
Journal of Colloid and Interface Science|July 22, 2011
Study on the wettability of polyethylene film fabricated at lower temperatureWeixin Hou, Lizhi Zhang, Yi Long
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic AlterationsSi-Yang Liu, Yi-Long Wu
Therapeutic Advances in Respiratory Disease|March 2, 2016
Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidenceE-E Ke, Yi-Long Wu
Science Bulletin|January 20, 2023
An immunological storm for cancer therapy: 2018 Nobel Prize in Physiology or MedicineSi-Yang Liu, Yi-Long Wu
Expert Opinion on Investigational Drugs|October 12, 2020
Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)Si-Yang Liu, Yi-Long Wu
Pageof 162

Showing results (31-40 of 1,614) with videos related to

Sort By:
Pageof 162
Biosensors|December 27, 2024
Entropy-Driven Molecular Beacon Assisted Special RCA Assay with Enhanced Sensitivity for Room Temperature DNA BiosensingShurui Tao, Yi Long, Guozhen Liu
Biochemical Genetics|July 14, 2023
Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and Prognosis BiomarkersLi Yang, Yi Long, Shengshi Xiao
Biosensors & Bioelectronics|December 25, 2010
Sensitive and isothermal electrochemiluminescence gene-sensing of Listeria monocytogenes with hyperbranching rolling circle amplification technologyYi Long, Xiaoming Zhou, Da Xing
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[Survival and Prognosis Analysis of 57 Patients with Multiple Myeloma]Yi-Fei Chen, Yi-Long Lu
Oncotargets and Therapy|May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibFei-Yu Niu, Yi-Long Wu
Journal of Colloid and Interface Science|July 22, 2011
Study on the wettability of polyethylene film fabricated at lower temperatureWeixin Hou, Lizhi Zhang, Yi Long
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic AlterationsSi-Yang Liu, Yi-Long Wu
Therapeutic Advances in Respiratory Disease|March 2, 2016
Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidenceE-E Ke, Yi-Long Wu
Science Bulletin|January 20, 2023
An immunological storm for cancer therapy: 2018 Nobel Prize in Physiology or MedicineSi-Yang Liu, Yi-Long Wu
Expert Opinion on Investigational Drugs|October 12, 2020
Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)Si-Yang Liu, Yi-Long Wu
Pageof 162